Is the development of antinuclear antibodies and antidouble-stranded DNA antibodies on antitumour necrosis factor treatments a marker of treatment failure in psoriasis?

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)45 - 46
Number of pages2
JournalBritish Journal of Dermatology
Volume161
Publication statusPublished - 2009
Event89th Annual Meeting of the British Association of Dermatologists - Glasgow, Scotland
Duration: 7 Jul 200910 Jul 2009

Cite this